Andere Sprachen Qiagen N.V.

Aktien

A400D5

NL0015001WM6

QGEN

Biotechnologie

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 13.01.2025			% 5 Tage	% 1. Jan.
46.00 ^USD	+2.95%		+2.29%	+3.30%

13.01.	Qiagen N.V. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 11:15 AM
13.01.	Steigende Renditen bereiten Anlegern weiter Kopfschmerzen	DJ

Andere Sprachen

Qiagen N : Commerzbank and ODDO BHF, German Investment Seminar Presentation	13.01.
Qiagen N : J.P. Morgan 2025 Healthcare Conference Investor Presentation January 13, 2025	13.01.
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples	13.01.
Qiagen Plans $300 Million Synthetic Share Repurchase	13.01.
QIAGEN to Return Approximately $300 Million to Shareholders Through a Synthetic Share Repurchase	12.01.
QIAGEN N.V.: QIAGEN to return approximately $300 million to shareholders through a synthetic share repurchase	12.01.
Qiagen Expands QIAcuity Digital PCR System's Capacity	10.01.
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples	10.01.
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights from Biological Samples	10.01.
Qiagen Gets U.S. Clearance for Gastrointestinal-Illness Test	09.01.
Qiagen Receives FDA Clearance for Gastrointestinal Panel Tests	09.01.
QIAGEN secures U.S. clearance for first QIAstat-Dx mini gastrointestinal panel to support year-round outpatient care	09.01.
QIAGEN Secures U.S. Clearance for First QIAstat-Dx Mini Gastrointestinal Panel to Support Year-round Outpatient Care	09.01.
QIAGEN Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content	07.01.
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data	12.12.
QIAGEN Launches Ingenuity Pathway Analysis Interpret	12.12.
Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally	05.12.
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation	05.12.
Qiagen Seeks Bolt-On Acquisitions	04.12.
Qiagen Plans to Open New Facility in Spain in 2026	29.11.
QIAGEN Strengthens QIAstat-Dx With New Barcelona Site to Drive Growth in Infectious Diseases and Precision Medicine Testing	28.11.
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis	27.11.
QIAGEN Launches Novel Tools for Customizing Digital PCR Assays and NGS Panels for Microbial Analysis	27.11.
Qiagen N : Citi’s Global Healthcare Conference Investor Introduction	26.11.
Qiagen N : Wolfe Research Healthcare Conference 2024 Investor Introduction	15.11.

Werden Sie Mitglied, um Zugang zu mehr Nachrichten zu erhalten.

100% kostenlose Registrierung

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Schlagzeilen

QIAGEN : Die Märkte begrüßten den Q3-Schlag + die Verbesserung der Profitabilität

Am 07. November 2024 um 13:20 Uhr